Legislators
Bills
Statements
Lobbying
Travel
- Bills
- S.516
S.516: Prescription Drug Monitoring Act of 2019
About This Bill
- This bill was introduced in the 116th Congress
- This bill is primarily about health
- Introduced Feb. 14, 2019
- Latest Major Action Feb. 14, 2019
- See the one similar bills introduced in other congresses.
Bill Sponsor
Bill Cosponsors
3 (1 Democrat, 1 Independent Democrat, 1 Republican)
Bill Version
- Introduced in Senate - Feb. 14, 2019
Bill Summary
Prescription Drug Monitoring Act of 2019 This bill expands the notification and reporting requirements with respect to potentially addictive prescription drugs for states receiving funds for a Prescription Drug Monitoring Program (PDMP). Dispensers of these drugs, which includes substances listed in schedule II, III, or IV of the Controlled Substances Act, must consult with the PDMP before starting treatment involving such drugs and report...
(Source: Library of Congress)
Bill Actions
Date | Description |
---|---|
Feb. 14, 2019 |
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
|
Feb. 14, 2019 |
Introduced in the Senate by Amy Klobuchar (D-Minn.) |